Officials are assessing whether hydromethylthionine mesylate (HMTM) shows sufficient promise to be given the green light for NHS patients. The drug attacks a protein called tau which accumulates ...

Imatinib mesylate has anti-inflammatory properties, because it is a specific and potent inhibitor of several protein tyrosine kinases. Paniagua et al. have investigated imatinib's mechanism of ...

IMKELDI offers a liquid formulation of imatinib mesylate, a tyrosine kinase inhibitor. It is designed for use in adults and paediatric patients as young as one, targeting acute lymphoblastic ...